EyePoint CFO shifts 139,906 shares into trusts

EyePoint, Inc. (EYPT) reported internal equity transfers by Chief Financial Officer George Elston on August 20, 2026.

Rhea-AI Filing Summary

EyePoint, Inc. (EYPT) reported internal equity transfers by Chief Financial Officer George Elston on August 20, 2026. A total of 5,000 shares of common stock were shifted from an irrevocable family trust into Elston’s direct ownership, while 64,953 shares were transferred as a bona fide gift from his direct holdings into a grantor-retained annuity trust (GRAT) he serves as grantor, trustee and beneficiary. The family trust continues to hold 25,000 shares for the benefit of his children, and Elston disclaims beneficial ownership of those trust-held shares.

Insider Trade Summary

129,906 shares gifted

Gift 4 txns

Insider Elston George

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Other	Common Stock F1, F2	5,000	$0.00	$0.00
Other	Common Stock F1	5,000	$0.00	$0.00
Gift	Common Stock F3, F4	64,953	$0.00	$0.00
Gift	Common Stock F3, F5	64,953	$0.00	$0.00

Holdings After Transaction: Common Stock — 25,000 shares (Indirect, By Family Trust); Common Stock — 32,517 shares (Direct); Common Stock — 64,953 shares (Indirect, By GRAT)

Footnotes (5)

1. F1. On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company from an irrevocable family trust of which JP Morgan Trust Company of Delaware is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust").
2. F2. These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3. F3. On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company to the GEORGE O. ELSTON 2026 GRAT (the "GRAT"), a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary.
4. F4. Includes 779 shares acquired on July 31, 2026, pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
5. F5. These securities are held in the GRAT, a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary.

Key Figures

Restructuring transfers: 10,000 shares Gift transfers: 129,906 shares Family Trust holdings: 25,000 shares +3 more

6 metrics

Restructuring transfers 10,000 shares Total shares in J-code restructuring transfers on August 20, 2026

Gift transfers 129,906 shares Aggregate shares in G-code bona fide gifts on August 20, 2026

Family Trust holdings 25,000 shares Indirect EyePoint common stock held by Family Trust after J-code disposition

GRAT holdings 64,953 shares Indirect EyePoint common stock held by the 2026 GRAT after G-code acquisition

RestructuringShares 10,000 shares RestructuringShares in transactionSummary for code J transfers

GiftShares 129,906 shares GiftShares in transactionSummary for code G bona fide gifts

Key Terms

bona fide gift, grantor-retained annuity trust, indirect ownership, beneficial ownership

4 terms

bona fide gift financial

"transaction_code_description": "Bona fide gift""

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

grantor-retained annuity trust financial

"the GEORGE O. ELSTON 2026 GRAT (the "GRAT"), a grantor-retained annuity trust"

indirect ownership financial

""ownership_type": "indirect""

beneficial ownership financial

"The reporting person disclaims beneficial ownership of these securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did EYPT CFO George Elston report on August 20, 2026?

George Elston reported restructuring and gift transactions involving 5,000 shares moved from a family trust to his direct ownership and 64,953 shares transferred as a bona fide gift from his direct holdings into a grantor-retained annuity trust (GRAT). All were at a reported price of $0.00 per share.

Did the EYPT Form 4 show any open-market buying or selling of shares?

No. The reported transactions for EYPT involved restructuring transfers (code J) and bona fide gifts (code G) at $0.00 per share, not open-market purchases or sales, and thus did not change Elston’s position through market trading.

How many EYPT shares were moved between Elston and the family trust?

Elston’s Form 4 shows 5,000 shares of EyePoint common stock transferred from an irrevocable family trust, reducing that trust’s indirect holdings to 25,000 shares and increasing Elston’s direct ownership by the same 5,000-share amount.

What is the size of the EYPT share gift to the GRAT reported by Elston?

Elston reported a bona fide gift of 64,953 shares of EyePoint common stock from his direct holdings to the GEORGE O. ELSTON 2026 GRAT, a grantor-retained annuity trust where he is grantor, trustee and beneficiary. The GRAT’s post-transaction balance is 64,953 shares held indirectly.

Does Elston claim beneficial ownership of the EYPT shares in the family trust?

No. Footnotes state the Family Trust holds shares for the benefit of Elston’s children, with JP Morgan Trust Company of Delaware as trustee, and that Elston disclaims beneficial ownership of those securities for Section 16 and any other purpose.

Were the reported EYPT insider transactions made under a Rule 10b5-1 plan?

No. The Form 4’s Rule 10b5-1 checkbox is not checked, and the footnotes do not reference any trading plan, indicating these transfers and gifts were not reported as being executed under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:11 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elston George

(Last) (First) (Middle)

C/O EYEPOINT, INC.

480 PLEASANT STREET, SUITE C400

(Street)

WATERTOWN MASSACHUSETTS 02472

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EyePoint, Inc. [ EYPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2026		J(1)		5,000	D	$0.00	25,000	I	By Family Trust(2)
Common Stock	08/20/2026		J(1)		5,000	A	$0.00	96,691	D
Common Stock	08/20/2026		G(3)		64,953	D	$0.00	32,517(4)	D
Common Stock	08/20/2026		G(3)		64,953	A	$0.00	64,953	I	By GRAT(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company from an irrevocable family trust of which JP Morgan Trust Company of Delaware is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust").

2. These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

3. On August 20, 2026, the reporting person transferred owned shares of Common Stock of the Company to the GEORGE O. ELSTON 2026 GRAT (the "GRAT"), a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary.

4. Includes 779 shares acquired on July 31, 2026, pursuant to EyePoint's 2019 Employee Stock Purchase Plan.

5. These securities are held in the GRAT, a grantor-retained annuity trust, to which the reporting person is a grantor, trustee and beneficiary.

Remarks:

	/s/ Ron Honig, Attorney-in-Fact	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)